Global Market Reports

US newspaper round-up: Europe blows its chance of building a defence giant

Date: Thursday 11 Oct 2012

GlaxoSmithKline plans to open up much of its drug research in an apparent effort to deflect criticism that important information gathered in clinical trials often does not see the light of day. The move, a first for a major pharmaceutical company, is scheduled to be announced on Thursday by its chief...

Sign up for free or to read the full story

Email this article to a friend

or share it with one of these popular networks:


Top of Page